Surgery Partners Aktie
WKN DE: A14YWP / ISIN: US86881A1007
08.01.2024 14:38:23
|
Surgery Partners Backs Annual Revenue Guidance In Line With Estimates
(RTTNews) - Surgery Partners, Inc. (SGRY), a short-stay surgical facility owner and operator, on Monday reaffirmed its full-year guidance revenue outlook in line with the Street view.
For the full year, excluding items, the company still expects EBITDA of $436 million to $440 million.
Surgery Partners continues to expect annual revenue of around $2.75 billion.
On average, 10 analysts polled by Thomson Reuters expect SGRY to register revenue of $2.75 billion, for the year. Analysts' estimates typically exclude special items.
For the full year 2024, consistent with its commitment to drive mid-teens growth, the company projects an adjusted EBITDA of over $495 million.
SGRY was trading down by 0.19 percent at $31 per share in the pre-market trade on the Nasdaq.

Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Surgery Partners Incmehr Nachrichten
04.08.25 |
Ausblick: Surgery Partners legt Zahlen zum jüngsten Quartal vor (finanzen.net) | |
21.07.25 |
Erste Schätzungen: Surgery Partners stellt Ergebnisse des abgelaufenen Quartals vor (finanzen.net) | |
11.05.25 |
Ausblick: Surgery Partners verkündet Quartalsergebnis zum jüngsten Jahresviertel (finanzen.net) | |
27.04.25 |
Erste Schätzungen: Surgery Partners mit Zahlen zum abgelaufenen Quartal (finanzen.net) |
Analysen zu Surgery Partners Incmehr Analysen
Aktien in diesem Artikel
Surgery Partners Inc | 18,60 | 1,64% |
|